BiomeSense key facts
as of Oct 2026- Developer of an integrated precision measurement and analytics platform designed to transform microbiome data generation and analysis.
- BiomeSense is valued at approximately $19.2M as of Oct 2026 (last reported valuation).
- It has raised $16.2M across 3 recorded rounds; the latest was Early Stage VC ($7.1M) in Jul 2025.
- Notable investors include US National Science Foundation, SOSV, Service Provider Capital, IndieBio, Labcorp Venture Fund — 23 tracked in total.
- BiomeSense has filed 2 Form Ds with the SEC since 2019, most recently Dec 2023 ($6.2M sold to 33 investors).
- Status: Privately Held (backing).
BiomeSense's last reported valuation, Dec 2023. Nothing priced has surfaced since.
- ·The complete investor list: 23 names
- ·Watch BiomeSense: the Monday email on marks, rounds and moves
BiomeSense funding rounds
3 roundsWho backs BiomeSense
23+Membership and data by Private Market View
BiomeSense valuation
BiomeSense's last reported valuation was $19.2 million in Dec 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has BiomeSense raised?
BiomeSense has raised $16.2 million across 3 recorded rounds since 2019. The largest was a $7.1 million early-stage round in Jul 2025.
BiomeSense has filed 2 Form Ds with the SEC since 2019, most recently in Dec 2023 ($6.2 million sold to 33 investors).
BiomeSense investors
23 investors are on record for BiomeSense, including US National Science Foundation, SOSV, Service Provider Capital and IndieBio. By type, the record holds 5 venture capital firms and 1 family office. The early-stage round in Jul 2025 drew 27 investors.
About BiomeSense
Developer of an integrated precision measurement and analytics platform designed to transform microbiome data generation and analysis. The company's platform produces and analyzes large-scale, densely longitudinal microbiome datasets to discover, validate, and commercialize novel microbiome biomarkers at scale, enabling doctors to gain insights into understanding and leveraging the microbiome for human health.
- Sector
- Healthcare
- HQ
- Chicago, IL, United States
- Founded
- 2018
- Employees
- 9
- Website
- biomesense.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.